全文获取类型
收费全文 | 11563篇 |
免费 | 928篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 130篇 |
儿科学 | 327篇 |
妇产科学 | 284篇 |
基础医学 | 1552篇 |
口腔科学 | 404篇 |
临床医学 | 1339篇 |
内科学 | 2152篇 |
皮肤病学 | 114篇 |
神经病学 | 973篇 |
特种医学 | 532篇 |
外国民族医学 | 1篇 |
外科学 | 1946篇 |
综合类 | 159篇 |
一般理论 | 7篇 |
预防医学 | 1075篇 |
眼科学 | 262篇 |
药学 | 517篇 |
中国医学 | 7篇 |
肿瘤学 | 729篇 |
出版年
2021年 | 158篇 |
2020年 | 92篇 |
2019年 | 133篇 |
2018年 | 165篇 |
2017年 | 141篇 |
2016年 | 146篇 |
2015年 | 202篇 |
2014年 | 271篇 |
2013年 | 366篇 |
2012年 | 505篇 |
2011年 | 498篇 |
2010年 | 325篇 |
2009年 | 277篇 |
2008年 | 451篇 |
2007年 | 530篇 |
2006年 | 502篇 |
2005年 | 405篇 |
2004年 | 458篇 |
2003年 | 460篇 |
2002年 | 443篇 |
2001年 | 395篇 |
2000年 | 423篇 |
1999年 | 362篇 |
1998年 | 138篇 |
1997年 | 114篇 |
1996年 | 142篇 |
1995年 | 119篇 |
1994年 | 125篇 |
1993年 | 103篇 |
1992年 | 290篇 |
1991年 | 273篇 |
1990年 | 253篇 |
1989年 | 250篇 |
1988年 | 219篇 |
1987年 | 225篇 |
1986年 | 241篇 |
1985年 | 253篇 |
1984年 | 212篇 |
1983年 | 128篇 |
1982年 | 91篇 |
1981年 | 90篇 |
1979年 | 161篇 |
1978年 | 105篇 |
1977年 | 97篇 |
1976年 | 97篇 |
1975年 | 83篇 |
1974年 | 103篇 |
1972年 | 100篇 |
1971年 | 81篇 |
1969年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
11.
12.
Gastrointestinal dysfunction among intensive care unit patients 总被引:3,自引:0,他引:3
This study used the Acute Physiological and Chronic Health Evaluation (APACHE II) system to select two groups of ICU patients with comparable risk of hospital death to evaluate the importance of GI dysfunction, defined as failure to tolerate enteral nutrition (EN), as a prognostic factor. In our ICU, patients who have not undergone recent bowel surgery are treated by EN. Those patients who cannot tolerate EN are treated by total parenteral nutrition (TPN). One hundred and eleven patients who tolerated EN (functioning gut) and 97 TPN patients who failed to tolerate EN (GI dysfunction) were studied. The mean APACHE II scores of the two groups were 17.7 +/- 6.5 (SD) and 17.7 +/- 5.1, respectively. The observed mortality of patients with GI dysfunction (51%) was significantly higher (p less than .0005) than that of patients with a functioning gut (25%). This was associated with significantly poorer APACHE II mean BP, oxygenation, and creatinine scores among the GI dysfunction patients. Our results suggest that shock, ischemia, and hypoxemia, in addition to causing impairment of renal function, may bring about changes in the GI tract, evident clinically only as a failure to tolerate EN, which have an adverse effect on the prognosis of ICU patients so affected. 相似文献
13.
14.
Albert J Finestone Michael R Jacobs John A Cacciamani 《Clinical Interventions in Aging》2007,2(4):715-718
Critical to survival is the geriatric concept, allostasis, defined as the ability to achieve stability through change. It is appropriate that allostasis is an introduction to this commentary, which may partially apply to the medical and pharmacy profession as currently constituted. 相似文献
15.
W R Jacobs 《Immunobiology》1992,184(2-3):147-156
16.
17.
18.
19.
Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique 总被引:1,自引:0,他引:1
J G Reves N D Croughwell E Hawkins L R Smith J R Jacobs S Rankin J Lowe P VanTrigt 《The Journal of thoracic and cardiovascular surgery》1990,100(2):221-227
Esmolol, administered as a bolus followed by continuous infusion, was used to treat the occurrence of transient tachycardia and hypertension or tachycardia alone before cardiopulmonary bypass in 45 patients. The study was conducted in two phases. Phase I (15 patients) was a dose-finding study and phase II (30 patients) was a randomized, double-blind, placebo-controlled efficacy study. All patients received the last dose of their usual beta-adrenergic blocker the night before the operation and were anesthetized with midazolam, vecuronium, and enflurane in oxygen. Treatment criteria were either a systolic blood pressure greater than 140 mm Hg and a heart rate greater than 70 or a heart rate greater than 80 beats/min. In phase I, graduated doses of esmolol were given to successive patients. A dose of 80 mg followed by a 12 mg/min infusion was declared effective. Phase II patients were randomized to receive esmolol (n = 16) or placebo (n = 14). Hemodynamic data were collected at baseline and 1, 3, 5, and 10 minutes after the administration of esmolol. Plasma norepinephrine was measured at baseline, 1, and 10 minutes. Esmolol significantly (p less than 0.05) reduced heart rate at 1, 3, 5, and 10 minutes but did not change blood pressure, pulmonary artery diastolic pressure, right atrial pressure, cardiac output, or systemic vascular resistance. Our results show that a bolus loading dose of esmolol is safe and effective in the treatment of tachycardia in patients with ischemic heart disease and that esmolol rapidly blocks the beta-adrenergic effects of norepinephrine associated with surgical stress. 相似文献
20.
C Movsowitz L A Podolsky C B Meyerowitz L E Jacobs M N Kotler 《Journal of the American Society of Echocardiography》1992,5(3):259-270
A patent foramen ovale (PFO) is an embryological remnant found in 27% of adults. It is a potential right-to-left intracardiac shunt. Shunting may be the result of reversal in the interatrial pressure gradient or abnormal streaming of blood in the right atrium. The pathologic consequences of right-to-left shunting include hypoxemia and paradoxical embolism. PFO may exacerbate preexisting hypoxemia or be its primary cause. Paradoxical embolism through a PFO is well documented. Its role in cryptogenic stroke remains controversial. A PFO may be detected by both invasive and noninvasive techniques. Contrast transesophageal echocardiography with provocative maneuvers is the diagnostic method of choice allowing visualization of the shunt. Patients with cryptogenic stroke should be screened for a PFO. If detected, noninvasive studies for deep vein thrombosis are recommended. Treatment must be tailored to the presentation. Surgical or transcatheter closure is recommended for hypoxemia. Prevention of venous embolism (air or thrombus) with or without closure of the PFO is recommended for paradoxical embolism. 相似文献